This content is only available within our institutional offering.

18 Oct 2017
PANMURE: PG:GP – Issue 5
Advanced Medical Solutions Group plc (AMS:LON), 213 | Allergy Therapeutics plc (AGY:LON), 6.8 | Animalcare Group PLC (ANCR:LON), 298 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 26.6 | Faron Pharmaceuticals Oy (FARN:LON), 215 | ImmuPharma plc (IMM:LON), 2.7 | MaxCyte, Inc. (MXCT:LON), 166 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 10.5 | Venture Life Group Plc (VLG:LON), 53.5 | HUTCHMED (China) Limited (HCM:LON), 222 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: PG:GP – Issue 5
Advanced Medical Solutions Group plc (AMS:LON), 213 | Allergy Therapeutics plc (AGY:LON), 6.8 | Animalcare Group PLC (ANCR:LON), 298 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 26.6 | Faron Pharmaceuticals Oy (FARN:LON), 215 | ImmuPharma plc (IMM:LON), 2.7 | MaxCyte, Inc. (MXCT:LON), 166 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 10.5 | Venture Life Group Plc (VLG:LON), 53.5 | HUTCHMED (China) Limited (HCM:LON), 222 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0
- Published:
18 Oct 2017 -
Author:
Dr Julie Simmonds -
Pages:
29 -